Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer

Advanced-stage epithelial ovarian cancers are amongst the most difficult to treat tumors and have proven to be refractory to most cytotoxic, molecularly targeted, or immunotherapeutic approaches. Here, we report that nanoparticle-drug conjugates (NDCs) of monomethyl auristatin E (MMAE) significantly...

Full description

Bibliographic Details
Main Authors: Lauffer, Sam, Matulonis, Ursula, Pepin, David, Birrer, Michael J., Qi, Ruogu, Wang, Yongheng, Bruno, Peter Michael, Xiao, Haihua, Yu, Yingjie, Li, Ting, Chen, Qixian, Kang, Xiang, Song, Haiqin, Yang, Xi, Huang, Xing, Detappe, Alexandre, Hemann, Michael, Ghoroghchian, Paiman Peter, Wei, Wei, S.M. Massachusetts Institute of Technology. Department of Civil and Environmental Engineering
Other Authors: Koch Institute for Integrative Cancer Research at MIT
Format: Article
Published: Nature Publishing Group 2018
Online Access:http://hdl.handle.net/1721.1/113634
https://orcid.org/0000-0001-5088-5810
https://orcid.org/0000-0003-3383-0118
https://orcid.org/0000-0002-2515-5602
_version_ 1826199262084464640
author Lauffer, Sam
Matulonis, Ursula
Pepin, David
Birrer, Michael J.
Qi, Ruogu
Wang, Yongheng
Bruno, Peter Michael
Xiao, Haihua
Yu, Yingjie
Li, Ting
Chen, Qixian
Kang, Xiang
Song, Haiqin
Yang, Xi
Huang, Xing
Detappe, Alexandre
Hemann, Michael
Ghoroghchian, Paiman Peter
Wei, Wei, S.M. Massachusetts Institute of Technology. Department of Civil and Environmental Engineering
author2 Koch Institute for Integrative Cancer Research at MIT
author_facet Koch Institute for Integrative Cancer Research at MIT
Lauffer, Sam
Matulonis, Ursula
Pepin, David
Birrer, Michael J.
Qi, Ruogu
Wang, Yongheng
Bruno, Peter Michael
Xiao, Haihua
Yu, Yingjie
Li, Ting
Chen, Qixian
Kang, Xiang
Song, Haiqin
Yang, Xi
Huang, Xing
Detappe, Alexandre
Hemann, Michael
Ghoroghchian, Paiman Peter
Wei, Wei, S.M. Massachusetts Institute of Technology. Department of Civil and Environmental Engineering
author_sort Lauffer, Sam
collection MIT
description Advanced-stage epithelial ovarian cancers are amongst the most difficult to treat tumors and have proven to be refractory to most cytotoxic, molecularly targeted, or immunotherapeutic approaches. Here, we report that nanoparticle-drug conjugates (NDCs) of monomethyl auristatin E (MMAE) significantly increase loading on a per-vehicle basis as compared to antibody-drug conjugates (ADCs). Their intraperitoneal administration enabled triggered release of the active MMAE toxin to inhibit tumor growth and to extend animal survival to > 90 days in a cell-line xenograft model of disseminated ovarian cancer. In a patient-derived xenograft model of advanced-stage and platinum-resistant ovarian cancer, an MMAE-based NDC doubled the duration of tumor growth inhibition as compared to cisplatin. NDCs of highly potent toxins thus introduce a translatable platform that may be exploited to maximize the safety and efficacy of cytotoxic chemotherapies, combining the best features of ADCs with those of nanoparticle-based therapeutics.
first_indexed 2024-09-23T11:17:16Z
format Article
id mit-1721.1/113634
institution Massachusetts Institute of Technology
last_indexed 2024-09-23T11:17:16Z
publishDate 2018
publisher Nature Publishing Group
record_format dspace
spelling mit-1721.1/1136342022-09-27T18:28:07Z Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer Lauffer, Sam Matulonis, Ursula Pepin, David Birrer, Michael J. Qi, Ruogu Wang, Yongheng Bruno, Peter Michael Xiao, Haihua Yu, Yingjie Li, Ting Chen, Qixian Kang, Xiang Song, Haiqin Yang, Xi Huang, Xing Detappe, Alexandre Hemann, Michael Ghoroghchian, Paiman Peter Wei, Wei, S.M. Massachusetts Institute of Technology. Department of Civil and Environmental Engineering Koch Institute for Integrative Cancer Research at MIT Qi, Ruogu Wang, Yongheng Bruno, Peter Michael Xiao, Haihua Yu, Yingjie Li, Ting Chen, Qixian Kang, Xiang Song, Haiqin Yang, Xi Huang, Xing Detappe, Alexandre Hemann, Michael Ghoroghchian, Paiman Peter Advanced-stage epithelial ovarian cancers are amongst the most difficult to treat tumors and have proven to be refractory to most cytotoxic, molecularly targeted, or immunotherapeutic approaches. Here, we report that nanoparticle-drug conjugates (NDCs) of monomethyl auristatin E (MMAE) significantly increase loading on a per-vehicle basis as compared to antibody-drug conjugates (ADCs). Their intraperitoneal administration enabled triggered release of the active MMAE toxin to inhibit tumor growth and to extend animal survival to > 90 days in a cell-line xenograft model of disseminated ovarian cancer. In a patient-derived xenograft model of advanced-stage and platinum-resistant ovarian cancer, an MMAE-based NDC doubled the duration of tumor growth inhibition as compared to cisplatin. NDCs of highly potent toxins thus introduce a translatable platform that may be exploited to maximize the safety and efficacy of cytotoxic chemotherapies, combining the best features of ADCs with those of nanoparticle-based therapeutics. 2018-02-13T19:08:37Z 2018-02-13T19:08:37Z 2017-12 2017-09 2018-02-09T14:51:25Z Article http://purl.org/eprint/type/JournalArticle 2041-1723 http://hdl.handle.net/1721.1/113634 Qi, Ruogu et al. “Nanoparticle Conjugates of a Highly Potent Toxin Enhance Safety and Circumvent Platinum Resistance in Ovarian Cancer.” Nature Communications 8, 1 (December 2017): 2166 © 2017 The Author(s) https://orcid.org/0000-0001-5088-5810 https://orcid.org/0000-0003-3383-0118 https://orcid.org/0000-0002-2515-5602 http://dx.doi.org/10.1038/s41467-017-02390-7 Nature Communications Creative Commons Attribution 4.0 International License https://creativecommons.org/licenses/by/4.0/ application/pdf Nature Publishing Group
spellingShingle Lauffer, Sam
Matulonis, Ursula
Pepin, David
Birrer, Michael J.
Qi, Ruogu
Wang, Yongheng
Bruno, Peter Michael
Xiao, Haihua
Yu, Yingjie
Li, Ting
Chen, Qixian
Kang, Xiang
Song, Haiqin
Yang, Xi
Huang, Xing
Detappe, Alexandre
Hemann, Michael
Ghoroghchian, Paiman Peter
Wei, Wei, S.M. Massachusetts Institute of Technology. Department of Civil and Environmental Engineering
Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer
title Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer
title_full Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer
title_fullStr Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer
title_full_unstemmed Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer
title_short Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer
title_sort nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer
url http://hdl.handle.net/1721.1/113634
https://orcid.org/0000-0001-5088-5810
https://orcid.org/0000-0003-3383-0118
https://orcid.org/0000-0002-2515-5602
work_keys_str_mv AT lauffersam nanoparticleconjugatesofahighlypotenttoxinenhancesafetyandcircumventplatinumresistanceinovariancancer
AT matulonisursula nanoparticleconjugatesofahighlypotenttoxinenhancesafetyandcircumventplatinumresistanceinovariancancer
AT pepindavid nanoparticleconjugatesofahighlypotenttoxinenhancesafetyandcircumventplatinumresistanceinovariancancer
AT birrermichaelj nanoparticleconjugatesofahighlypotenttoxinenhancesafetyandcircumventplatinumresistanceinovariancancer
AT qiruogu nanoparticleconjugatesofahighlypotenttoxinenhancesafetyandcircumventplatinumresistanceinovariancancer
AT wangyongheng nanoparticleconjugatesofahighlypotenttoxinenhancesafetyandcircumventplatinumresistanceinovariancancer
AT brunopetermichael nanoparticleconjugatesofahighlypotenttoxinenhancesafetyandcircumventplatinumresistanceinovariancancer
AT xiaohaihua nanoparticleconjugatesofahighlypotenttoxinenhancesafetyandcircumventplatinumresistanceinovariancancer
AT yuyingjie nanoparticleconjugatesofahighlypotenttoxinenhancesafetyandcircumventplatinumresistanceinovariancancer
AT liting nanoparticleconjugatesofahighlypotenttoxinenhancesafetyandcircumventplatinumresistanceinovariancancer
AT chenqixian nanoparticleconjugatesofahighlypotenttoxinenhancesafetyandcircumventplatinumresistanceinovariancancer
AT kangxiang nanoparticleconjugatesofahighlypotenttoxinenhancesafetyandcircumventplatinumresistanceinovariancancer
AT songhaiqin nanoparticleconjugatesofahighlypotenttoxinenhancesafetyandcircumventplatinumresistanceinovariancancer
AT yangxi nanoparticleconjugatesofahighlypotenttoxinenhancesafetyandcircumventplatinumresistanceinovariancancer
AT huangxing nanoparticleconjugatesofahighlypotenttoxinenhancesafetyandcircumventplatinumresistanceinovariancancer
AT detappealexandre nanoparticleconjugatesofahighlypotenttoxinenhancesafetyandcircumventplatinumresistanceinovariancancer
AT hemannmichael nanoparticleconjugatesofahighlypotenttoxinenhancesafetyandcircumventplatinumresistanceinovariancancer
AT ghoroghchianpaimanpeter nanoparticleconjugatesofahighlypotenttoxinenhancesafetyandcircumventplatinumresistanceinovariancancer
AT weiweismmassachusettsinstituteoftechnologydepartmentofcivilandenvironmentalengineering nanoparticleconjugatesofahighlypotenttoxinenhancesafetyandcircumventplatinumresistanceinovariancancer